vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.

RANGE RESOURCES CORP is the larger business by last-quarter revenue ($786.9M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs -10.1%, a 32.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 18.0%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 14.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.

CLOV vs RRC — Head-to-Head

Bigger by revenue
RRC
RRC
1.6× larger
RRC
$786.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+26.8% gap
CLOV
44.7%
18.0%
RRC
Higher net margin
RRC
RRC
32.9% more per $
RRC
22.8%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
14.6%
RRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
RRC
RRC
Revenue
$487.7M
$786.9M
Net Profit
$-49.3M
$179.1M
Gross Margin
94.5%
Operating Margin
-10.1%
Net Margin
-10.1%
22.8%
Revenue YoY
44.7%
18.0%
Net Profit YoY
-123.2%
88.8%
EPS (diluted)
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
RRC
RRC
Q4 25
$487.7M
$786.9M
Q3 25
$496.6M
$655.3M
Q2 25
$477.6M
$699.6M
Q1 25
$462.3M
$846.3M
Q4 24
$337.0M
$667.0M
Q3 24
$331.0M
$567.9M
Q2 24
$356.3M
$513.2M
Q1 24
$346.9M
$598.8M
Net Profit
CLOV
CLOV
RRC
RRC
Q4 25
$-49.3M
$179.1M
Q3 25
$-24.4M
$144.3M
Q2 25
$-10.6M
$237.6M
Q1 25
$-1.3M
$97.1M
Q4 24
$-22.1M
$94.8M
Q3 24
$-9.2M
$50.7M
Q2 24
$7.4M
$28.7M
Q1 24
$-19.2M
$92.1M
Gross Margin
CLOV
CLOV
RRC
RRC
Q4 25
94.5%
Q3 25
92.5%
Q2 25
95.0%
Q1 25
93.1%
Q4 24
93.7%
Q3 24
24.5%
94.3%
Q2 24
30.3%
93.4%
Q1 24
23.6%
94.7%
Operating Margin
CLOV
CLOV
RRC
RRC
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
RRC
RRC
Q4 25
-10.1%
22.8%
Q3 25
-4.9%
22.0%
Q2 25
-2.2%
34.0%
Q1 25
-0.3%
11.5%
Q4 24
-6.6%
14.2%
Q3 24
-2.8%
8.9%
Q2 24
2.1%
5.6%
Q1 24
-5.5%
15.4%
EPS (diluted)
CLOV
CLOV
RRC
RRC
Q4 25
$0.75
Q3 25
$0.60
Q2 25
$0.99
Q1 25
$0.40
Q4 24
$0.38
Q3 24
$0.21
Q2 24
$0.12
Q1 24
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
RRC
RRC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$204.0K
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$308.7M
$4.3B
Total Assets
$541.0M
$7.4B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
RRC
RRC
Q4 25
$78.3M
$204.0K
Q3 25
$175.0K
Q2 25
$134.0K
Q1 25
$344.6M
Q4 24
$194.5M
$304.5M
Q3 24
$288.0M
$277.4M
Q2 24
$254.8M
$251.1M
Q1 24
$208.3M
$343.1M
Total Debt
CLOV
CLOV
RRC
RRC
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.8B
Stockholders' Equity
CLOV
CLOV
RRC
RRC
Q4 25
$308.7M
$4.3B
Q3 25
$340.9M
$4.2B
Q2 25
$344.2M
$4.1B
Q1 25
$336.1M
$3.9B
Q4 24
$341.1M
$3.9B
Q3 24
$342.2M
$3.9B
Q2 24
$324.9M
$3.9B
Q1 24
$292.5M
$3.8B
Total Assets
CLOV
CLOV
RRC
RRC
Q4 25
$541.0M
$7.4B
Q3 25
$559.7M
$7.2B
Q2 25
$575.0M
$7.1B
Q1 25
$583.7M
$7.4B
Q4 24
$580.7M
$7.3B
Q3 24
$653.0M
$7.2B
Q2 24
$674.2M
$7.3B
Q1 24
$671.8M
$7.4B
Debt / Equity
CLOV
CLOV
RRC
RRC
Q4 25
0.28×
Q3 25
0.29×
Q2 25
0.29×
Q1 25
0.43×
Q4 24
0.43×
Q3 24
0.44×
Q2 24
0.44×
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
RRC
RRC
Operating Cash FlowLast quarter
$-66.9M
$257.5M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
RRC
RRC
Q4 25
$-66.9M
$257.5M
Q3 25
$12.1M
$247.5M
Q2 25
$5.4M
$336.2M
Q1 25
$-16.3M
$330.1M
Q4 24
$34.8M
$217.9M
Q3 24
$50.0M
$245.9M
Q2 24
$44.8M
$148.8M
Q1 24
$25.9M
$331.9M
Free Cash Flow
CLOV
CLOV
RRC
RRC
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
RRC
RRC
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
RRC
RRC
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
RRC
RRC
Q4 25
1.44×
Q3 25
1.72×
Q2 25
1.42×
Q1 25
3.40×
Q4 24
2.30×
Q3 24
4.85×
Q2 24
6.04×
5.18×
Q1 24
3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

RRC
RRC

Natural Gas Natural Gas Liquids And Oil Sales$745.5M95%
Brokered Natural Gas And Marketing$41.3M5%

Related Comparisons